Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) EBITDA Margin (2016)

Microbot Medical's EBITDA Margin history spans 7 years, with the latest figure at 5737.96% for Q3 2016.

  • For the quarter ending Q3 2016, EBITDA Margin rose 2123458.0% year-over-year to 5737.96%, compared with a TTM value of 25453.42% through Sep 2016, down 2154571.0%, and an annual FY2015 reading of 31415.32%, changed N/A over the prior year.
  • EBITDA Margin for Q3 2016 was 5737.96% at Microbot Medical, up from 30309.28% in the prior quarter.
  • The five-year high for EBITDA Margin was 826.99% in Q1 2012, with the low at 42674.62% in Q1 2015.
  • Average EBITDA Margin over 5 years is 18705.6%, with a median of 18852.32% recorded in 2013.
  • Year-over-year, EBITDA Margin crashed -2820687bps in 2015 and then surged 2123458bps in 2016.
  • Tracing MBOT's EBITDA Margin over 5 years: stood at 2917.39% in 2012, then plummeted by -582bps to 19907.16% in 2013, then skyrocketed by 94bps to 1101.83% in 2014, then crashed by -2560bps to 29308.7% in 2015, then surged by 80bps to 5737.96% in 2016.
  • Per Business Quant, the three most recent readings for MBOT's EBITDA Margin are 5737.96% (Q3 2016), 30309.28% (Q2 2016), and 42366.93% (Q1 2016).